TapewireFind a company

person · Reporting owner

FOATE DEAN A

Disclosed activity across 2 companies

Tapewire entity
67116
SEC CIK
0001223189

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
PLEXUS CORPPLXS · Entity 3761Director · Chairman of the BoardFebruary 06, 2026February 10, 2026
REGAL REXNORD CORPRBC · Entity 2107DirectorMay 06, 2021May 07, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

PLEXUS CORP

Report date February 06, 2026 · Filed February 10, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $.01 par valueSEC Table I · non-derivativeDirect99,429 Reported balance After 2026-02-06 transaction · row 2
1 source row

Row 2 · 2026-02-06 · Sale · Disposed 10,000 · Balance 99,429

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect1,008 Reported balance After 2026-02-09 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-02-09 · Grant · Acquired 1,008 · Balance 1,008

F2: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 9, 2027.

Common Stock, $.01 par valueSEC Table I · non-derivativeIndirectTrust15,000 Reported balance Holding disclosure · report date 2026-02-06 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 15,000

F1: Shares of Plexus Corp. common stock held in a trust for which the reporting person is a trustee.

Filing footnotes · ownership attribution and instrument terms

F1: Shares of Plexus Corp. common stock held in a trust for which the reporting person is a trustee.

F2: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 9, 2027.

REGAL REXNORD CORP

Report date May 06, 2021 · Filed May 07, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect21,441 Reported balance After 2021-05-06 transaction · row 1
1 source row

Row 1 · 2021-05-06 · Grant · Acquired 970 · Balance 21,441

F1: Restricted shares granted to the reporting person under the 2018 Equity Incentive Plan. Restricted shares are non-transferable until 5/6/2022.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted shares granted to the reporting person under the 2018 Equity Incentive Plan. Restricted shares are non-transferable until 5/6/2022.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 09, 2026 Filed Feb 10, 2026 21:50 UTC PLEXUS CORP PLXS · Entity 3761 GrantRestricted Stock Units · Derivative 1,008 Not disclosed Not disclosed
Disclosure

SEC source: 0001223189-26-000005 · wk-form4_1770760210.xml · derivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,008

Underlying: Common Stock, $.01 par value · 1,008 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 9, 2027.

F2 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 9, 2027.

F2 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 9, 2027.

F2 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 9, 2027.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 21:50 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 10,000 $205.00 $2,050,000.00
Disclosure

SEC source: 0001223189-26-000005 · wk-form4_1770760210.xml · nonDerivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,429

Read SEC document
February 03, 2026 Filed Feb 4, 2026 22:48 UTC PLEXUS CORP PLXS · Entity 3761 Exercise / conversionRestricted Stock Units · Derivative 1,370 Not disclosed Not disclosed
Disclosure

SEC source: 0001223189-26-000004 · wk-form4_1770245290.xml · derivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.01 par value · 1,370 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on February 3, 2026.

F2 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on February 3, 2026.

F2 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on February 3, 2026.

F2 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on February 3, 2026.

Read SEC document
February 03, 2026 Filed Feb 4, 2026 22:48 UTC PLEXUS CORP PLXS · Entity 3761 Exercise / conversionCommon Stock, $.01 par value 1,370 Not disclosed Not disclosed
Disclosure

SEC source: 0001223189-26-000004 · wk-form4_1770245290.xml · nonDerivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,429

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on February 3, 2026.

Read SEC document
February 02, 2026 Filed Feb 4, 2026 22:48 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 5,000 $204.89 $1,024,467.50
Disclosure

SEC source: 0001223189-26-000004 · wk-form4_1770245290.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Indirect · Trust

Disclosed balance after: 15,000

F1 · ownership.nature: Shares of Plexus Corp. common stock held in a trust for which the reporting person is a trustee.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 22:12 UTC PLEXUS CORP PLXS · Entity 3761 GrantRestricted Stock Units · Derivative 1,325 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-004109 · wk-form4_1738793531.xml · derivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,325

Underlying: Common Stock, $.01 par value · 1,325 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 3, 2026.

F2 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 3, 2026.

F2 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 3, 2026.

F2 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 3, 2026.

Read SEC document
February 03, 2025 Filed Nov 3, 2025 21:22 UTC Amendment PLEXUS CORP PLXS · Entity 3761 GrantRestricted Stock Units · Derivative 1,370 Not disclosed Not disclosed
Disclosure

SEC source: 0001223189-25-000006 · wk-form4a_1762204952.xml · derivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,370

Underlying: Common Stock, $.01 par value · 1,370 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 3, 2026.

F1 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 3, 2026.

F1 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 3, 2026.

F1 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on February 3, 2026.

Read SEC document
January 29, 2025 Filed Jan 31, 2025 21:34 UTC PLEXUS CORP PLXS · Entity 3761 Exercise / conversionRestricted Stock Units · Derivative 1,979 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-003324 · wk-form4_1738359248.xml · derivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.01 par value · 1,979 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 29, 2025.

F2 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 29, 2025.

F2 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 29, 2025.

F2 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 29, 2025.

Read SEC document
January 29, 2025 Filed Jan 31, 2025 21:34 UTC PLEXUS CORP PLXS · Entity 3761 Exercise / conversionCommon Stock, $.01 par value 1,979 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-003324 · wk-form4_1738359248.xml · nonDerivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,059

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 29, 2025.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 22:25 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 1,100 $163.04 $179,343.12
Disclosure

SEC source: 0001628280-24-049319 · wk-form4_1732659940.xml · nonDerivative · entry 4

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,080

F4 · price: This transaction was executed in multiple trades at prices ranging from $163.00 to $163.19 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 25, 2024 Filed Nov 26, 2024 22:25 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 6,807 $164.20 $1,117,687.62
Disclosure

SEC source: 0001628280-24-049319 · wk-form4_1732659940.xml · nonDerivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,180

F3 · price: This transaction was executed in multiple trades at prices ranging from $164.05 to $164.56500 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 25, 2024 Filed Nov 26, 2024 22:25 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 2,093 $163.09 $341,353.86
Disclosure

SEC source: 0001628280-24-049319 · wk-form4_1732659940.xml · nonDerivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,987

F2 · price: This transaction was executed in multiple trades at prices ranging from $163.00 to $163.945 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 08, 2024 Filed Nov 13, 2024 21:12 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 2,500 $167.11 $417,764.25
Disclosure

SEC source: 0001628280-24-047605 · wk-form4_1731532345.xml · nonDerivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Indirect · Trust

Disclosed balance after: 20,000

F1 · ownership.nature: Shares of Plexus Corp. common stock held in a trust for which the reporting person is a trustee. The trust's holdings of Plexus Corp. common stock were inadvertently omitted from the reporting person's prior filings.

Read SEC document
January 30, 2024 Filed Jan 31, 2024 21:11 UTC PLEXUS CORP PLXS · Entity 3761 Exercise / conversionRestricted Stock Units · Derivative 1,821 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-002726 · wk-form4_1706735465.xml · derivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.01 par value · 1,821 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 30, 2024.

F1 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 30, 2024.

F1 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 30, 2024.

F1 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 30, 2024.

Read SEC document
January 30, 2024 Filed Jan 31, 2024 21:11 UTC PLEXUS CORP PLXS · Entity 3761 Exercise / conversionCommon Stock, $.01 par value 1,821 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-002726 · wk-form4_1706735465.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,080

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 30, 2024.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 21:11 UTC PLEXUS CORP PLXS · Entity 3761 GrantRestricted Stock Units · Derivative 1,979 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-002726 · wk-form4_1706735465.xml · derivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,979

Underlying: Common Stock, $.01 par value · 1,979 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 29, 2025.

F2 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 29, 2025.

F2 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 29, 2025.

F2 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 29, 2025.

Read SEC document
January 31, 2023 Filed Feb 1, 2023 21:28 UTC PLEXUS CORP PLXS · Entity 3761 Exercise / conversionRestricted Stock Units · Derivative 1,918 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-005915 · doc4.xml · derivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,918 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 31, 2023.

F1 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 31, 2023.

F1 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 31, 2023.

F1 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 31, 2023.

Read SEC document
January 31, 2023 Filed Feb 1, 2023 21:28 UTC PLEXUS CORP PLXS · Entity 3761 Exercise / conversionCommon Stock, $.01 par value 1,918 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-005915 · doc4.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 31, 2023.

Read SEC document
January 30, 2023 Filed Feb 1, 2023 21:28 UTC PLEXUS CORP PLXS · Entity 3761 GrantRestricted Stock Units · Derivative 1,821 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-005915 · doc4.xml · derivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,821

Underlying: Common Stock · 1,821 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 30, 2024.

F2 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 30, 2024.

F2 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 30, 2024.

F2 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 30, 2024.

Read SEC document
January 31, 2022 Filed Feb 2, 2022 21:29 UTC PLEXUS CORP PLXS · Entity 3761 GrantRestricted Stock Units · Derivative 1,918 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-006381 · doc4.xml · derivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,918

Underlying: Common Stock · 1,918 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 31, 2023.

F1 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 31, 2023.

F1 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 31, 2023.

F1 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 31, 2023.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 21:55 UTC PLEXUS CORP PLXS · Entity 3761 Exercise / conversionRestricted Stock Units · Derivative 2,069 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-005089 · doc4.xml · derivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,069 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 25, 2022.

F1 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 25, 2022.

F1 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 25, 2022.

F1 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 25, 2022.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 21:55 UTC PLEXUS CORP PLXS · Entity 3761 Exercise / conversionCommon Stock, $.01 par value 2,069 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-005089 · doc4.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,341

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 25, 2022.

Read SEC document
May 06, 2021 Filed May 7, 2021 20:19 UTC REGAL REXNORD CORP RBC · Entity 2107 GrantCommon Stock 970 $0.00 $0.00
Disclosure

SEC source: 0000082811-21-000068 · wf-form4_162041873158106.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,441

F1 · shares: Restricted shares granted to the reporting person under the 2018 Equity Incentive Plan. Restricted shares are non-transferable until 5/6/2022.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 22:10 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 5,057 $86.58 $437,840.62
Disclosure

SEC source: 0001209191-21-017016 · doc4.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,272

F1 · price: This transaction was executed in multiple trades at prices ranging from $86.50 to $86.73 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 27, 2021 Filed Jan 27, 2021 21:17 UTC PLEXUS CORP PLXS · Entity 3761 Exercise / conversionRestricted Stock Units · Derivative 2,216 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-005647 · doc4.xml · derivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,216 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 27, 2021.

F1 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 27, 2021.

F1 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 27, 2021.

F1 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 27, 2021.

Read SEC document
January 27, 2021 Filed Jan 27, 2021 21:17 UTC PLEXUS CORP PLXS · Entity 3761 Exercise / conversionCommon Stock, $.01 par value 2,216 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-005647 · doc4.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,329

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 27, 2021.

F1 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on January 27, 2021.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 21:17 UTC PLEXUS CORP PLXS · Entity 3761 GrantRestricted Stock Units · Derivative 2,069 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-005647 · doc4.xml · derivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,069

Underlying: Common Stock · 2,069 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 25, 2022.

F2 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 25, 2022.

F2 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 25, 2022.

F2 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 25, 2022.

Read SEC document
January 07, 2021 Filed Jan 7, 2021 21:19 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 4,000 $85.50 $342,000.00
Disclosure

SEC source: 0001209191-21-002495 · doc4.xml · nonDerivative · entry 5

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 0

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
January 06, 2021 Filed Jan 7, 2021 21:19 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 4,000 $84.50 $338,000.00
Disclosure

SEC source: 0001209191-21-002495 · doc4.xml · nonDerivative · entry 4

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 4,000

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
January 06, 2021 Filed Jan 7, 2021 21:19 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 4,000 $83.50 $334,000.00
Disclosure

SEC source: 0001209191-21-002495 · doc4.xml · nonDerivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 8,000

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
January 05, 2021 Filed Jan 7, 2021 21:19 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 4,000 $82.50 $330,000.00
Disclosure

SEC source: 0001209191-21-002495 · doc4.xml · nonDerivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 12,000

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
December 18, 2020 Filed Dec 22, 2020 19:23 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 4,000 $81.50 $326,000.00
Disclosure

SEC source: 0001209191-20-064799 · doc4.xml · nonDerivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 16,000

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
November 25, 2020 Filed Nov 27, 2020 23:03 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 1,600 $76.85 $122,960.00
Disclosure

SEC source: 0001209191-20-060658 · doc4.xml · nonDerivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,113

Read SEC document
November 24, 2020 Filed Nov 27, 2020 23:03 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 5,900 $78.17 $461,219.52
Disclosure

SEC source: 0001209191-20-060658 · doc4.xml · nonDerivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,713

F2 · price: This transaction was executed in multiple trades at prices ranging from $78.00 to $78.37 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 22:07 UTC REGAL REXNORD CORP RBC · Entity 2107 SaleCommon Stock 5,000 $118.34 $591,697.50
Disclosure

SEC source: 0000082811-20-000136 · wf-form4_160573725655065.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,471

Read SEC document
August 11, 2020 Filed Aug 11, 2020 21:09 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 7,900 $80.51 $635,999.77
Disclosure

SEC source: 0001209191-20-046179 · doc4.xml · nonDerivative · entry 4

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,151

F3 · price: This transaction was executed in multiple trades at prices ranging from $80.50 to $80.52 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 11, 2020 Filed Aug 11, 2020 21:09 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 4,000 $80.50 $322,000.00
Disclosure

SEC source: 0001209191-20-046179 · doc4.xml · nonDerivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 20,000

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
August 10, 2020 Filed Aug 11, 2020 21:09 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 4,000 $79.50 $318,000.00
Disclosure

SEC source: 0001209191-20-046179 · doc4.xml · nonDerivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 24,000

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
August 07, 2020 Filed Aug 11, 2020 21:09 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 4,000 $78.50 $314,000.00
Disclosure

SEC source: 0001209191-20-046179 · doc4.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 28,000

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
August 06, 2020 Filed Aug 7, 2020 22:39 UTC REGAL REXNORD CORP RBC · Entity 2107 SaleCommon Stock 7,500 $96.51 $723,841.50
Disclosure

SEC source: 0000082811-20-000110 · wf-form4_159683942433324.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,471

F1 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $96.50 to $96.69. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.

Read SEC document
August 05, 2020 Filed Aug 5, 2020 22:02 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 6,000 $77.53 $465,184.80
Disclosure

SEC source: 0001209191-20-045245 · doc4.xml · nonDerivative · entry 5

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,051

F4 · price: This transaction was executed in multiple trades at prices ranging from $77.45 to $77.68 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 05, 2020 Filed Aug 5, 2020 22:02 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 4,000 $77.50 $310,000.00
Disclosure

SEC source: 0001209191-20-045245 · doc4.xml · nonDerivative · entry 4

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 32,000

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
August 03, 2020 Filed Aug 5, 2020 22:02 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 4,000 $76.50 $306,000.00
Disclosure

SEC source: 0001209191-20-045245 · doc4.xml · nonDerivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 36,000

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
August 03, 2020 Filed Aug 5, 2020 22:02 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 4,000 $75.52 $302,064.00
Disclosure

SEC source: 0001209191-20-045245 · doc4.xml · nonDerivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 40,000

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $75.50 to $75.52 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
August 03, 2020 Filed Aug 5, 2020 22:02 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 4,000 $74.50 $298,000.00
Disclosure

SEC source: 0001209191-20-045245 · doc4.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 44,000

F1 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
July 29, 2020 Filed Jul 31, 2020 20:25 UTC PLEXUS CORP PLXS · Entity 3761 SaleCommon Stock, $.01 par value 5,459 $73.51 $401,293.82
Disclosure

SEC source: 0001209191-20-044265 · doc4.xml · nonDerivative · entry 3

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 48,000

F3 · kind: Shares were sold pursuant to a Rule 10b5-1 plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $73.50 to $73.61 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
May 06, 2020 Filed May 8, 2020 20:07 UTC REGAL REXNORD CORP RBC · Entity 2107 GrantCommon Stock 2,035 $0.00 $0.00
Disclosure

SEC source: 0000082811-20-000063 · wf-form4_158896845530537.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,971

F1 · shares: Restricted shares granted to the reporting person under the 2018 Equity Incentive Plan. Restricted shares are non-transferable until 5/6/2021.

Read SEC document
April 15, 2020 Filed Jul 31, 2020 20:25 UTC PLEXUS CORP PLXS · Entity 3761 GiftCommon Stock, $.01 par value 53,459 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-044265 · doc4.xml · nonDerivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LLC

Disclosed balance after: 53,459

F1 · price: The reported transaction involved a gift of securities by the reporting person to a family-owned entity in which family members of the reporting person have an indirect interest through trusts for which the reporting person is a trustee.

F2 · ownership.nature: Shares of Plexus Corp. common stock held in a family-owned entity controlled by the reporting person.

Read SEC document
April 15, 2020 Filed Jul 31, 2020 20:25 UTC PLEXUS CORP PLXS · Entity 3761 GiftCommon Stock, $.01 par value 53,459 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-044265 · doc4.xml · nonDerivative · entry 1

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,051

F1 · price: The reported transaction involved a gift of securities by the reporting person to a family-owned entity in which family members of the reporting person have an indirect interest through trusts for which the reporting person is a trustee.

Read SEC document
January 27, 2020 Filed Jan 29, 2020 21:43 UTC PLEXUS CORP PLXS · Entity 3761 GrantRestricted Stock Units · Derivative 2,216 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-005375 · doc4.xml · derivative · entry 2

FOATE DEAN A · CIK 0001223189 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,216

Underlying: Common Stock · 2,216 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 27, 2021.

F1 · price: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 27, 2021.

F1 · derivative.exercise_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 27, 2021.

F1 · derivative.expiration_date: Each Restricted Stock Unit granted under the Plexus Corp. 2016 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represents a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vest on January 27, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.